TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $736,000 | +237.6% | 9,784 | +114.1% | 0.03% | +400.0% |
Q4 2021 | $218,000 | -30.4% | 4,570 | -3.1% | 0.01% | -40.0% |
Q3 2021 | $313,000 | -14.9% | 4,718 | 0.0% | 0.01% | -9.1% |
Q2 2021 | $368,000 | -16.7% | 4,718 | +1.0% | 0.01% | -15.4% |
Q1 2021 | $442,000 | -26.3% | 4,673 | -5.1% | 0.01% | -31.6% |
Q4 2020 | $600,000 | +13.9% | 4,923 | -18.5% | 0.02% | 0.0% |
Q3 2020 | $527,000 | +35.1% | 6,038 | 0.0% | 0.02% | +26.7% |
Q2 2020 | $390,000 | +6.0% | 6,038 | -26.7% | 0.02% | -11.8% |
Q1 2020 | $368,000 | – | 8,240 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |